Featured Speakers
Aripta Bhowmick
Director, Global Omni Channel Contact Center Technology, Digital
MODERNA
Bill Trombetta
Attorney/Consultant
Cristina Damatarca
Senior Vice President of Drug Safety and Pharmacovigilance
XENON PHARMACEUTICALS
Dewey Seto
Associate Director, US REMS Strategy & Submission Program Lead
BRISTOL MYERS SQUIBB
Dr Siva Kumar
Global Pharmacovigilance Physician Senior Manager
TEVA
Edward D. Millikan, PharmD, RPh
Senior Clinical Informatics Pharmacist
Division of Mitigation Assessment and Medication Error Surveillance (DMAMES)
Office of Medication Error Prevention and Risk Management (OMEPRM)
Office of Surveillance and Epidemiology (OSE) CDER
FDA
Eleni Allen
Risk Evaluation & Mitigation Strategy Lead
GSK
Ernie Anastasi
Director, Technical Operations
Examoto a UBC Company
George Neyarapally, PharmD, JD, MPH, RPh
Regulatory Science Research Policy Lead
Regulatory Science & Applied Research Team OSE | CDER
FDA
Jacqueline Gerena
Program Management (REMS Program)
AIMMUNE THERAPEUTICS
James Curtis
Director, Software Development Engineer
UBC
Jaylaxmi Nalawade
Associate Director Pharmacovigilance and REMS
LUPIN
Kal Elhoregy
Director , REMS Programs, Regulatory Affairs Clinical
AMNEAL PHARMCEUTICALS
Marc DeLuca
US Risk Management Lead
SANOFI
Marcin von Grotthuss
Principal Scientist, Investigative Toxicology
TAKEDA
Matt Page
Post Marketing Safety Studies Team Lead
TAKEDA
Michael von Forstner
Head of Clinical Safety and Pharmacovigilance
BIOGEN
Neha Rana
Risk Management Lead, REMS & Risk Management Center of Excellence
JANSSEN
Samuel Ewusie
Senior Manager, Global Risk Management
BRISTOL MYERS SQUIBB
Suzanne McLeod
Associate Director, REMS
Hikma Pharmaceuticals